SNTI 8-K 2026-11-10

Senti Biosciences Holdings, Inc. (SNTI) 8-K dated 2026-11-10 — accession 0001628280-26-072793.

Senti Biosciences Holdings, Inc. (SNTI) is a biotechnology company listed on NASDAQ.

Senti Biosciences Holdings, Inc. filed a 8-K on 2026-11-10. Accession 0001628280-26-072793.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SNTI revenue for 2025-12-31 was $22.0K. Net income was -$61.4M. SNTI currently screens at market cap $29.6M.

Not investment advice. The SNTI SEC hub lists recent forms. The stock page is the research view.